Philip M. Hansbro
- Emergency Medical Services top 0.05%
- Pediatric health and respiratory diseases 68
- Immunology top 0.2%
- IL-33, ST2, and ILC Pathways 53
- Immune Response and Inflammation 24
- Physiology top 0.2%
- Asthma and respiratory diseases 111
- Pulmonary and Respiratory Medicine top 0.2%
- Chronic Obstructive Pulmonary Disease (COPD) Research 58
- Neonatal Respiratory Health Research 42
- Inhalation and Respiratory Drug Delivery 26
- Microbiology top 0.5%
-
- Gut microbiota and health 23
Philip M. Hansbro
480 papers receiving 19.6k citations
Hit Papers
Peers
Comparison fields: 5 of 191
- Emergency Medical Services 1.9k
- Immunology 4.7k
- Physiology 4.6k
- Pulmonary and Respiratory Medicine 5.3k
- Microbiology 700
Countries citing papers authored by Philip M. Hansbro
This map shows the geographic impact of Philip M. Hansbro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip M. Hansbro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip M. Hansbro more than expected).
Fields of papers citing papers by Philip M. Hansbro
This network shows the impact of papers produced by Philip M. Hansbro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip M. Hansbro. The network helps show where Philip M. Hansbro may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Philip M. Hansbro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 10 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 20 | |
| 7 | 2023 | 8 | |
| 8 | 2023 | 12 | |
| 9 | 2023 | 24 | |
| 10 | 2023 | 15 | |
| 11 | 2022 | 30 | |
| 12 | 2022 | 35 | |
| 13 | 2022 | 41 | |
| 14 | 2021 | 17 | |
| 15 | 2021 | 19 | |
| 16 | 2020 | 13 | |
| 17 | Necroptosis is activated in and drives pathogenesis of COPD | 2019 | 1 |
| 18 | 2013 | 170 | |
| 19 | 2013 | 2 | |
| 20 | 2008 | 95 |
About Philip M. Hansbro
Philip M. Hansbro is a scholar working on Emergency Medical Services, Immunology and Drug Discovery, having authored 485 papers that have together received 19.9k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (111 papers), Pediatric health and respiratory diseases (68 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (58 papers), IL-33, ST2, and ILC Pathways (53 papers), Neonatal Respiratory Health Research (42 papers), Inhalation and Respiratory Drug Delivery (26 papers), Immune Response and Inflammation (24 papers) and Gut microbiota and health (23 papers). The work is most often cited by research in Emergency Medical Services (1.9k citations), Immunology (4.7k citations) and Physiology (4.6k citations). Philip M. Hansbro has collaborated with scholars based in Australia, India and Malaysia. Frequent co-authors include Paul S. Foster, Kamal Dua, Jay C. Horvat, Kurtis F. Budden, Peter Wark, Peter G. Gibson, Philip Hugenholtz, Shaan L. Gellatly, Richard Kim and Matthew A. Cooper. Their work appears in journals such as Science, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.